We studied 232 dogs that underwent mastectomy for mammary epithelial neoplasms. The mastectomy specimens were evaluated according to structural parameters found to be prognostically significant in human mammary neoplasms, such as grade of atypia in non-invasive proliferations of duct epithelium, extent of malignant disease, and nuclear differentiation in malignant neoplasms. In this study, the biologic behavior of mammary lesions was assessed according to the frequency of development of de novo or recurrent invasive carcinoma within two years. Our data indicate that we can recognize structural variables which permit classification of mammary neoplasms into categories with distinct patterns of biologic behavior. In addition to normotypic proliferative lesions and invasive malignant neoplasms, we were able to identify precancerous atypic and non-invasive malignant neoplasms that are considered precursor lesions in women. Also, as in women, nuclear differentiation was found to be a prognostically significant variable. Lymphoid cellular reactions, considered to be structural correlates of host-tumor immune responses in women, were noted in 35% of dogs with precancerous or malignant neoplasms. Application of the described parameters should facilitate comparative studies of canine and human mammary carcinogenesis and use of the dog as a model for the development of new therapeutic modalities and immunoprophylaxis of human mammary cancer.
Several authors have proposed the dog as a model for human mammary neoplasia, based on many similarities that have been noted between the two species [9, 12, 17, [23] [24] [25] [30] [31] [32] [33] [34] . While the numerous publications on canine mammary neoplasms, including reports emphasizing clinical characteristics and epidemiologic features, appear to conflict regarding certain observations, a consensus has evolved about many characteristics such as age, glands affected, growth rate, metastatic patterns, clinical stage, types of surgical intervention and their efficacy, and influence of ovariohysterectomy [I2- 14, 17, 24-26, 29, 31-33, 35, 37) . The areas of considerable conflict are histologic classification and evaluation of prognosis. Only a few studies have attempted to correlate survival data with specific histologic characteristics [9, 13, 15, 23, 27] .
A number of classification systems have been advocated but none has been accepted universally [9, 15, [20] [21] [22] [23] [24] [25] [27] [28] [29] [30] . A World Health Organization committee, 127 in a series of detailed reports on a large population of mammary tumor dogs, has proposed a standard system of nomenclature and classification [20] [21] [22] . However, even this system has been found confusing and difficult to apply to various canine mammary neoplasms, and its prognostic validity has been questioned [IS, 27] . There obviously is need for a system that offers more uniformity and precision and that, above all, correlates more consistently with biologic behavior. The lack of such a system has limited the comparability of studies concerning the influence of factors such as breed and endocrinologic and immunologic status on mammary carcinogenesis and biologic behavior. Such limitation applies also to the evaluation of the effects .of different modes of therapy and, in particular, hinders the use of the dog as a model for human mammary neoplasia.
Our studies are aimed at recognition and definition of morphologic variables that affect the biologic behavior of canine mammary neoplasms. It became apparent that clearly defined parameters had to be established that permit reproducible classification of the various types of mammary proliferative lesions. We have adapted the human classification system, devised by Black [5, 6] , to the dog for our evaluation of mammary neoplasms in dogs with careful postoperative follow-up. This system is well documented in women as to histologic characteristics and their correlation with biologic behavior [3, 4, 6, 7, II] . It emphasizes numerical grading of various morphologic features and thereby allows a more precise and uniform classification of canine lesions. This should facilitate comparative studies of carcinogenesis and behavior in human and canine mammary neoplasia. Such studies specifically require the ability to identify, according to criteria recognized as prognostically relevant in women, subpopulations of dogs with mammary lesions of similar biologic behavior as that of corresponding human breast lesions.
Materials and Methods
For this study, 232 dogs with epithelial mammary neoplasms were selected from the mastectomy cases at The Animal Medical Center, New York, between 1974 and 1980. At mastectomy all clinically evident mammary masses were removed. Selection was based on accuracy of medical record notations with respect to site and side of primary and secondary masses and glands removed. Dogs that died of unrelated causes or had inadequate periodic clinical and radiographic monitoring or inadequate histologic specimens were excluded from this study. Selection also was based on the requirement for a minimum follow-up of two years or until documented development of mammary cancer, following primary surgery, for determination of the cancer-free interval. The cancer-free interval is defined as the time from primary mastectomy to documented development of de novo or recurrent mammary carcinoma. Time of recurrence was determined by clinical and radiographic examination by veterinary oncologists at The Animal Medical Center. In most instances, the diagnosis of de novo or recurrent carcinoma was confirmed by necropsy or biopsy. Since dogs with non-malignant lesions are more likely to be lost to long-term follow-up than dogs with malignant lesions, our study population has a certain over-representation of dogs with malignant neoplasms.
Evaluation of each dog included the review of hematoxylin and eosin-stained sections from each involved gland and of all removed lymph nodes. Multiple sections were examined from neoplasms larger than 3 cm in diameter. In instances when invasive mammary carcinoma was diagnosed, parenchyma which was free of invasive cancer was examined if available.
Identification of dogs suitable for the study . according to the described standards for accuracy of follow-up, and compilation of the follow-up results were done by a non-pathologist participant in this study (10K) with assistance of trained non-professional personnel. AI1 histologic evaluations were done by one veterinary pathologist (SRG). with regular consultation of M.M. Black, and completed without prior knowledge of the fol1ow-up results by the participating pathologists.
Classification system
The classification system for human mammary epithelial neoplasms by Black, as adapted to the dog, essentially is based on numerical grading of: a) degree of duct epithelial proliferation and of atypia in non-invasive neoplasms. b) degree of nuclear differentiation in malignant proliferative lesions, and c) intensity of lymphoid cel1ular reactions.
Duct grading: The mammary gland consists of branching extralobular ducts and intralobular ductules. Black and Chabon (5) identified four subdivisions: terminal lactiferous ducts, their major branches, intralobular ductules, and acini. It sometimes may be difficult to distinguish al1 subdivisions, however, identification of ducts as extralobular or intralobular can be made readily ( fig. I) . Consequently, for this study we have confined ourselves to a distinction between extralobular ducts and intralobular ductules. The grading of duct epithelial changes has been described in detail elsewhere (5) . Essential1y, each division of the mammary duct system is assigned a numerical grade from I to 5, reflecting the degree of atypia of duct epithelium as follows: duct grade I = normotypic and normoplastic epithelium cerous mastopathies are associated with increased risk of subsequent development of invasive carcinoma in women [3, 7] . Duct grade 5 lesions fulfill the cytologic criteria of overt malignancy and carry an even higher risk of development of invasive carcinoma in women. The duct grade recorded for each dog is the one designating the most severe atypia observed in any subdivision of the duct system. In instances of invasive carcinomas, duct grades are determined for parenchyma that is free of invasive carcinoma , whenever available . in order to evaluate the association of precancerous mastopathy and in situ carcinomas with invasive cancers.
Even though it sometimes is difficult to distinguish between two sequential duct grades, such distinction is important in order to identify lesions that are precancerous. An observation described elsewhere [5] aids in the distinction between normotypic and precancerous atypic lesions: Intra-epithelial lymphocytes which are common in normotypic lesions ( fig. 2a ). are infrequent in duct grade 3 and rare in duct grade 4 lesions.
Nuclear grading: Degree of nuclear differentiation, considered a morphologic correlate of tumor aggressiveness, is assessed for all malignant lesions. both in situ and invasive, as In most instances the same nuclear grade is found throughout the malignant areas in a given mastectomy specimen. If different degrees of nuclear differentiation are present in the same specimen, the nuclear grade designation of the least differentiated area is recorded. It should be noted that in the nuclear grading system, as devised by Black and used in the classification of human breast cancers, the numerical grade increases with increasing degrees of differentiation.
Lymphoid cellular reactions: The various morphologic patterns of lymphoid cellular reac- tions to neoplastic proliferation, as described for human breast cancer [I, 5, 6, 8) , also can be identified in canine mammary neoplasms. They are: a) diffuse lymphoid cellular infiltration of a neoplasm, consisting predominantly of plasma cells (fig. Sa), and b) perivenous lymphoid cellular infiltrates, i.e., accumulation of predominantly small lymphocytes around small veins adjacent to neoplastic foci ( fig. 5b ). In the dog, perivenous infiltrates appear to have a higher proportion of plasma cells than that observed in women.
The intensity of both types of lymphoid cellular reactions is graded from 0 to 3: 0 = absent, I = minimal, 2 = moderate, and 3 = marked. Analagous to the human system, we have designated grades 0 and I as negative and grades 2 and 3 as positive. Positive reactions are considered to be morphologic correlates of specific host-versus-tumor immune reactivity. Caution must be exercised not to misinterpret non-specific inflammation as specific hostversus-tumor reactivity; canine mammary neoplasms frequently develop such inflammatory reactions secondary to necrosis and/or leakage ofsecretion products into the stroma. Therefore, specific reactivity only can be assessed in areas free of necrosis or leakage.
Staging: All dogs with malignantmammary neoplasms were categorized according to extent of disease at initial mastectomy as follows: stage 0 = malignant epithelial cell proliferation confined to ducts and/or ductules without stromal invasion; stage I = invasive carcinoma limited to local structures without identifiable invasion of blood or lymphatic vessels; stage II = invasion of blood or lymphatic vessels and/or metastases to regional lymph nodes; and stage III = systemic metastasis. Stages 0 to II are based on histologic evaluation while stage III is based on clinical assessment.
Statistical evaluation
The biologic significance of the morphologic characteristics was tested using the method of measuring association in retrospective studies [19] . The likelihood that any morphologic characteristic is associated with an increased risk of developing de novo or recurrent mammary cancer less than two years after initial mastectomy was determined using the chi-square test for fourfold tables, corrected for small sample sizes, with one degree of freedom. The relative risk values recorded (CRR) were corrected for small sample sizes by addition of 0.50 to each cell. The 95% confidence limits (CL) of the corrected relative risk were calculated according to the forumula: 95% CL = anti-logalog.CkR ± 1.96 x standard error [log.CRR]).
In order to evaluate the correlation between any morphologic characteristic and biologic behavior, we have grouped the dogs with mammary neoplasms into four categories according to the major phases of mammary carcinogenesis, namely normotypic proliferation, precancerous mastopathy, stage 0 in situ carcinoma, and invasive carcinoma.
Results
We have identified 116 dogs with non-malignant and 116 dogs with malignant proliferative epithelial lesions of the mammary gland. Of the dogs with malignant neoplasms, 18 had systemic metastasis (stage III) at initial mastectomy. Dogs with stage III disease are not included in tables I and II since, by definition, they have no cancer-free interval.
As shown in table I, the risk among dogs with malignant neoplasms to develop recurrent invasive carcinoma within two years after mastectomy was decidedly higher than that among dogs with non-malignant lesions to develop de novo invasive carcinoma. Application of the duct grading system to all non-invasive proliferative lesions led first to the identification of two subpopulations of dogs with different risks, one with normotypic proliferations and one with non-invasive malignant neoplasms (in situ carcinomas): A significantly higher risk is associated with in situ carcinomas as compared to normotypic lesions (p < 0.0005). In the first two years after mastectomy, no significant difference was apparent between dogs with precancerous mastopathy and those with normotypic lesions. It is noteworthy, however, that when follow-up was extended beyond the two-year interval, 9/40 dogs with precancerous mastopathy developed invasive carcinomas compared with 2/76 dogs with normotypic lesions. This represents a nine-fold increase in relative risk (95% confidence limits = 2.10 to 38.47; p < 0.0025). Although the follow-up beyond two years was not uniform for all dogs, loss to follow-up can be assumed to be similar for the normotypic and precancerous mastopathy groups.
There is a direct correlation between the extent of malignant disease at the time of initial surgery and the risk of development of recurrent or second primary invasive carcinoma, i.e., the more advanced the stage of the disease the higher the risk. As shown in table I, dogs with invasive disease, stages I and II combined, show a more than 13-fold increased risk relative to those with non-invasive (stage 0) mammary cancer. Even when dogs with stage I disease are considered separately, a significant increase in risk is apparent relative to dogs with stage 0 disease (p < 0.005). In our series, the 95% recurrence rate among dogs with stage II disease represents a six-fold increase in risk compared to those with stage I disease.
As stated above, in all instances when invasive mammary carcinoma was diagnosed, we attempted to identify parenchyma which was free of invasive cancer. Among 100 dogs with invasive cancers, including stages I, II, and III, this was accomplished in 74 mastectomy specimens. In 50 (68%) of these specimens, foci of in situ carcinomas were identified, in 14 (19%) foci of precancerous mastopathy were present, and in the remaining 10 (13%) only normotypic parenchyma was observed.
To determine the predictive value of nuclear differentiation in mammary cancer in terms of biologic behavior, we grouped nuclear grades 2 and 3 carcinomas as differentiated for comparison to nuclear grade I, undifferentiated carcinomas. As illustrated in table II, such comparison, without regard to stage of the disease, shows a greater than 22-fold increase in risk to develop recurrent carcinoma among dogs with undifferentiated cancers. When each stage was considered separately, the only statistically significant difference was seen among dogs with stage I disease. Among dogs with stage II disease, no significant difference was apparent; the recurrence rate among those with differentiated cancers already exceeded 85%. Assessment of the predictive value of nuclear differentiation was not possible among dogs with stage 0 disease since, in our series, all stage 0 carcinomas were differentiated. Table III illustrates our observations regarding lymphoid cellular reactions in association with the various histologic categories. In the non-malignant categories, while no reactions were seen in normotypic lesions, reactions were found in 8/40 (200/0) dogs with precancerous mastopathy. In the malignant categories, lymphoid cellular reactions were identified in 7/16 (44%) dogs with in situ carcinomas and in 39/100 dogs with invasive carcinomas. While diffuse lymphoid cellular infiltration of the tumor itself and perivenous lymphoid cell infiltrates adjacent to the tumor reactions may occur simultaneously, diffuse lymphoid cellular reactions proportionately were most frequent in the undifferentiated invasive carcinoma category and least common in the precancerous mastopathy and in situ carcinoma categories. Conversely, perivenous lymphoid cellular infiltrates were observed most frequently in association with in situ and differentiated invasive carcinomas and rarely in undifferentiated carcinomas. It is noteworthy that perivenous lymphoid cellular infiltrates were the only type of lymphoid cellular reaction found in precancerous mastopathies. Determination of the prognostic significance of lymphoid cellular reactions in dogs with mammary cancer will require further study, including consideration of actual cancer-free intervals rather than use of the two-year endpoint.
In this report, no separate consideration of extralobular and intralobular lesions is presented since most tumors were extralobular in this series. More dogs with primarily intralobular lesions will have to be accrued before an assessment of possible differences in biologic behavior between these two subcategories can be made.
In addition to the 232 dogs with epithelial mammary neoplasms, we have identified 13 dogs with primary malignant mesenchymal mammary neoplasms that had adequate follow-up. None of these dogs had any identifiable malignant proliferations of the mammary duct epithelium. Twelve of the 13 dogs had recurrent disease, less than one year after mastectomy, typically in the form of extensive, locally destructive growth. Only one dog had a cancer-free interval of more than two years.
Discussion
The histologic heterogeneity observed in canine mammary neoplasms presents considerable difficulties in the design of a classification system that will assure reproducibility of a prognostically meaningful categorization. These difficulties are reflected by the number of classification systems proposed so far, as well as by the fact that none of these systems has been accepted universally. All proposed systems known to us are oriented toward recognition of tissue patterns which are identified by descriptive terminology. This approach appears to have prevented achievement of reproducibility and uniformity in the categorization of canine mammary neoplasms. Consequently, it has been difficult and more often impossible to compare results of studies by investigators from different institutions and to arrive at valid conclusions about the biologic characteristics of different types of mammary neoplasms. Furthermore, even though conceptually the dog appears to be a feasible model for human mammary neoplasia, the limitations of the currently available classification systems have so far impeded actual use of the dog as a model.
We have, therefore, chosen a different approach by using the classification system for human mammary neoplasms [5, 6] , adapted to the dog. This system permits considerable standardization by quantitative assessment of changes of the mammary epithelial cells according to precise criteria that have been well documented as to their prognostic effects in women [3, 4, 6, 7, II] . The results of our study indicate not only that these morphologic characteristics are identifiable in canine mammary neoplasms but that they correlate, similar to those in women, with distinct patterns of biologic behavior. It appears of particular importance that correlation was found irrespective of the frequently observed association of epithelial lesions with diverse stromal and myoepithelial metaplastic changes. This observation is consistent with those of several other studies indicating that it is predominantly the malignant epithelial cells that are responsible for progression of the disease to local recurrence or systemic metastasis [15, 27, 29, 31) .
In our study, the biologic relevance of a given parameter was assessed by determination of the cancer-free interval subsequent to the initial mastectomy. Other studies have attempted to correlate histologic features with biologic behavior by examining survival characteristics [9, 13, 15, 23, 27] . We found survival to be a problematic endpoint because of the frequency of interference with defined followup criteria by factors, such as various types of therapeutic intervention, death due to causes unrelated to mammary neoplasms, and euthanasia. According to our observations, assessment of post-operative cancer-free interval appears to be a useful and reasonable endpoint, since distinct differences in cancer-free intervals were observed among the various categories of lesions as defined by the structural parameters.
As judged by the two-year follow-up results, dogs diagnosed by our system as having malignant neoplasms were at decidedly higher risk to develop recurrent disease than were those with non-malignant lesions to develop de novo carcinomas. In our own institution, retrospective comparison of the diagnostic categorization of mammary lesions according to our system with that of previously applied systems revealed that a number of neoplasms considered non-malignant by our classification previously had been categorized as malignant. Inclusion of a larger or smaller proportion of actually non-malignant cases in the malignant category may account for some of the differences in relative frequency of canine mammary cancer in various reported series (12, 13, 15, 17, 26, 27, 29, 30, 32] . Also, this variable can be expected to result in marked variation in the findings of studies of the biologic behavior of mammary neoplasms.
Among dogs with neoplasms classified as non-malignant, we were able to identify two major subpopulations, i.e., those with lesions consisting of normotypic parenchyma and those with precancerous mastopathy, that is proliferative lesions showing atypia of moderate to marked degree but less than that seen in overt carcinoma. While follow-up limited to two years did not reveal a significant difference in biologic behavior between the two subpopulations, extension of the follow-up beyond two years showed a significantly higher risk of subsequent development of invasive carcinoma among dogs with precancerous mastopathy. These findings are consistent with observations on analogous subpopulations of women [3, 6, 7] . Our data indicate that the identification of the moderate to marked atypia of precancerous mastopathy is relevant prognostically and that precancerous mastopathies should, therefore, not be classified merely as "benign."
In addition to the above finding that dogs with neoplasms classified as malignant are overall more likely to develop recurrent or de novo invasive carcinomas following initial mastectomy than those with non-malignant neoplasms, we found a significant stepwise increase in risk with progression of the extent of disease at the time of primary surgery, i.e., stage 0 < stage I < stage II. The 95% recurrence rate among stage II dogs in our series illustrates a deleterious effect of lymph node metastasis or vascular invasion, when present at the time of primary surgery, on the prognosis. This observation is in contrast with results reported by others [23, 24] . According to our results, the biologic behavior of stage 0 carcinomas is significantly different from that of stage I as well as that of non-malignant neoplasms. This indicates that it is important to identify the pre-invasive phase of mammary carcinomas. Recognition of the pre-invasive phase has long been considered essential in human mammary cancer, not only because of its prognostic implications, but also because of its conceptual importance for the development of immunoprophylaxis [2, 8] . Pre-invasive malignant as well as precancerous atypic mammary epithelial proliferations are considered precursor lesions of invasive mammary cancer in women [3, 5, 7] . The fact that in the dog such precursor lesions can be identified and are associated with behavioral characteristics similar to those of their human counterparts, suggests strongly that the dog could serve as a model in studies of human mammary carcinogenesis and in the development of immunoprophylaxis.
It is noteworthy that, again similar to observations in women, we have found foci of precancerous mastopathy and in situ carcinoma coexistent with invasive cancer in, respectively, one-fifth and two-thirds of specimens. This observation as well as the association of each category of canine mammary neoplasms with distinct behavioral characteristics, as described, are in strong support of the concept of a progressive development suggested for canine mammary carcinogenesis [10, 15, 16, 18, 29, 31, 36] , analogous to the stepwise development suggested for women [2, [5] [6] [7] .
Our assessment of the predictive value of nuclear differentiation in mammary cancer in terms of biologic behavior was limited, by the number of dogs available in this series, to a distinction between undifferentiated (nuclear grade I) and moderately to well-differentiated (nuclear grades 2-3) carcinomas. Our data indicate that, similar to women [4, 6, 11] , nuclear differentiation represents a structural correlate of intrinsic aggressiveness of the cancer cell, i.e., the lesser the degree of nuclear differentiation, the higher the intrinsic aggressiveness of the neoplasm, as judged by the difference in frequency of development of recurrent disease within two years after initial mastectomy. Such distinction was only possible among stage I dogs since, in our series, all stage 0 carcinomas were moderately to well differentiated and since among dogs with stage II disease the recurrence rate exceeded 85%, regardless of the degree of nuclear differentiation. A larger series will be required to determine whether nuclear differentiation affects the prognosis of dogs with stage 0 carcinomas and whether there is a difference in biologic behavior between nuclear grade 2 and nuclear grade 3 carcinomas. The difference observed so far between the behavior of differentiated and that of undifferentiated stage I carcinomas does indicate that nuclear differentiation is a variable to be considered in the evaluation of the effects of secondary treatment modalities, such as radiation, chemo-and immunotherapy.
Even though the data we have accrued so far show no significant differences in biologic behavior between neoplasms with and without lymphoid cellular reactivity, it is noteworthy that diffuse lymphoid cellular infiltration and perivenous lymphoid cellular infiltrates, considered structural representations of specific host-tumor immune reactivity in women, were found in a significant proportion of precancerous atypic and of pre-invasive and invasive malignant lesions [1, 2, 4-6, 8]. While diffuse lymphoid cellular infiltration and perivenous lymphoid cellular infiltrates may occur simultaneously, we found that, similar to observations in human mammary cancer, diffuse cellular infiltrates were present most frequently in undifferentiated invasive carcinomas and least commonly in precursor lesions (1, 4, 6]. As mentioned before, perivenous lymphoid cellular reactions in the dog, most frequently found associated with in situ and differentiated invasive carcinomas, appear to have a somewhat higher representation of plasmacytoid cells than that seen in women. Further detailed studies on a larger number of dogs are required for an adequate assessment of the prognostic effects of these lymphoid cellular reactions in canine mammary neoplasms. Of particular interest at this stage of our investigation is the observation that 20% of dogs with precancerous mastopathy had perivenous lymphoid cellular reactions. The presence of such lymphoid cellular reactions in precancerous mastopathy suggests that, as in women, specific antigenic changes and host-tumor responses may appear during the earliest developmental phase of canine mammary carcinogenesis [2, 7, 8) .
Considered in toto, our data indicate that the described structural parameters, applied to canine mammary epithelial proliferative lesions, permit identification of variables that are prognostically significant. This approach to a classification of canine mammary neoplasms could facilitate significantly future studies of mammary carcinogenesis and of the biologic behavior of mammary neoplasms. Application of this system also would permit use of the dog as a model for human mammary cancer.
Finally, the ability to identify among mammary cancer dogs subpopulations with distinct biologic behavior is of great importance for studies of the effects of experimental adjuvant therapy regimens.
